Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

M.P. EVANS GROUP PLC Regulatory Filings 2023

Jan 3, 2023

7798_nav_2023-01-03_a7e3000c-59a2-4c70-ab6a-de06a09968ba.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 5202L

M. P. Evans Group PLC

03 January 2023

M.P. Evans Group PLC (the "Company")

Total voting rights

In conformity with Rule 5.6.1 of the FCA's Disclosure and Transparency Rules, the Company notifies the market that as at the date of this announcement, and assuming settlement of shares purchased prior to the date of this announcement pursuant to the Company's share buyback programme (announced on 16 June 2022) the Company's issued share capital comprises 54,221,769 shares of 10p each ("Shares"). All of the Shares have equal voting rights and there are no Shares held in treasury. 

This figure of 54,221,769 Shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

3 January 2023

LEI number: 2138003IBXJUCR4SZG26

Enquiries:

M.P. Evans Group PLC Telephone: +44 (0)1892 516333
Peter Hadsley-Chaplin - Executive chairman
Matthew Coulson - Chief executive
Peel Hunt LLP (Nomad and joint broker) Telephone: +44 (0)20 7418 8900
Dan Webster, Andrew Clark, Lalit Bose
finnCap (Joint broker) Telephone: +44 (0)20 7220 0500
Tim Redfern, Harriet Ward
Hudson Sandler (Communications consultants) Telephone:  +44 (0)20 7796 4133
Charlie Jack, Francis Kerrigan, Amelia Craddock

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRBDGDBLGGDGXX